Form 144 UroGen Pharma Ltd. Filed by: Degnan Chris
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 8-K GRAY MEDIA, INC For: Oct 08
false
0000043196
0000043196
2026-10-08
2026-10-08
0000043196
gtn:ClassACommonStockCustomMember
2026-10-08
2026-10-08
0000043196
gtn:CommonStockCustomMember
2026-10-08
2026-10-08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of... (continue reading...)
Form 8-K/A Atrium Therapeutics, For: Oct 07
true 0002093101 0002093101 2026-10-07 2026-10-07
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 7, 2026
Atrium Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 001-43008 39-4639499
Form 6-K SOLAI Ltd For: Oct 09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2026
Commission File Number: 001-36206
SOLAI Limited
428 South Seiberling Street
Akron, Ohio 44306
United States of America
+1 (346) 204-8537
Indicate by check mark whether the registrant files or will file annual... (continue reading...)
More SEC Filings
View Older Stories-
Form N-CEN LEGG MASON PARTNERS INCO For: Jul 31
-
Form 6-K Basel Medical Group Ltd For: Oct 09
-
Form 424B2 BofA Finance LLC
-
Form N-CEN Legg Mason Global Asset For: Jul 31
-
Form 8-K Transocean Ltd. For: Oct 09
-
Form 8-K PRUDENTIAL FINANCIAL For: Oct 09
-
Form 425 GigCapital8 Corp. Filed by: GigCapital8 Corp.
-
Form F-4 Scancell Holdings plc
-
Form 8-K GigCapital8 Corp. For: Oct 08
-
Form C Ronald Isley Liquid Gold
-
Form 4 CHECK POINT SOFTWARE For: Aug 05 Filed by: SHWED GIL
-
Form S-1/A CITY THERAPEUTICS, INC.
-
Form SCHEDULE 13D/A Gogoro Inc. Filed by: Gold Sino Assets Ltd
-
Form 424B2 BofA Finance LLC
-
Form EFFECT DarkIris Inc.
-
Form 424B2 PEPSICO INC
-
Form EFFECT TOP Financial Group Ltd
-
Form 425 RXO, Inc. Filed by: C. H. ROBINSON WORLDWIDE, INC.
-
Form RW Alzamend Neuro, Inc.
-
Form SCHEDULE 13D/A Melco Resorts & Entertai Filed by: Melco International Development LTD
-
Form EFFECT GEN Restaurant Group,
-
Form EFFECT Retension Pharmaceutical
-
Form 8-K Avalanche Treasury Corp For: Oct 07
-
Form EFFECT Nexera Technologies Ltd
-
Form 424B2 BARCLAYS BANK PLC
-
Form 6-K Chilwa Minerals Ltd For: Oct 09
-
Form 3 Hub Group, Inc. For: Oct 01 Filed by: Malik Thaddeus J.
-
Form 6-K ALTERITY THERAPEUTICS For: Oct 31
-
Form FWP JPMorgan Chase Financial Filed by: JPMorgan Chase Financial Co. LLC
-
Form 6-K Caledonia Mining Corp For: Oct 09
-
Form 10-Q Huineng Technology Corp For: Aug 31
-
Form 424B2 BARCLAYS BANK PLC
-
Form FWP BARCLAYS BANK PLC Filed by: BARCLAYS BANK PLC
-
Form EFFECT Bio Green Med Solution,
-
Form EFFECT FRANKLIN MUNICIPAL OPPOR
-
Form EFFECT TPG Mortgage Investment
-
Form 8-K HUMANA INC For: Oct 09
-
Form 4 Sea Ltd For: Oct 07 Filed by: Wang Yanjun
-
Form QUALIF RYSE Inc.
-
Form FWP INNOVATIVE INDUSTRIAL Filed by: INNOVATIVE INDUSTRIAL PROPERTIES INC
-
Form D/A PFDPRO MANAGEMENT FUND,
-
Form EFFECT FullPAC, Inc.
-
Form EFFECT SmartTrust 763
-
Form D DPEG Kanwa, LP
-
Form EFFECT FRANKLIN MANAGED MUNICIP
-
Form EFFECT TRex Bio, Inc.
-
Form EFFECT ECOMINAS CORP.
-
Form 6-K YPF SOCIEDAD ANONIMA For: Oct 08
-
Form D Pinnacle RE Services
-
Form 13F-HR McNaughton Wealth Manage For: Sep 30
